PICALM rescues glutamatergic neurotransmission, behavioural function and 
survival in a Drosophila model of Abeta42 toxicity

Yu, Y.; Niccoli, T.; Ren, Z.; Woodling, N. S.; Aleyakpo, B.; Szabadkai, G.; Partridge, L.

doi:10.1093/hmg/ddaa125

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Abeta42 toxicity

MPS-Authors

/persons/resource/persons129348

Partridge, L.
Department Partridge - Biological Mechanisms of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

https://www.ncbi.nlm.nih.gov/pubmed/32592479
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Yu, Y., Niccoli, T., Ren, Z., Woodling, N. S., Aleyakpo, B., Szabadkai, G., et al. (2020). PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Abeta42 toxicity. Hum Mol Genet, 29(14), 2420-2434. doi:10.1093/hmg/ddaa125.

Cite as: https://hdl.handle.net/21.11116/0000-000B-2DA2-C

Abstract

Alzheimer's disease (AD) is the most common form of dementia and the most prevalent neurodegenerative disease. Genome-wide association studies have linked PICALM to AD risk. PICALM has been implicated in Abeta42 production and turnover, but whether it plays a direct role in modulating Abeta42 toxicity remains unclear. We found that increased expression of the Drosophila PICALM orthologue lap could rescue Abeta42 toxicity in an adult-onset model of AD, without affecting Abeta42 level. Imbalances in the glutamatergic system, leading to excessive, toxic stimulation, have been associated with AD. We found that Abeta42 caused the accumulation of presynaptic vesicular glutamate transporter (VGlut) and increased spontaneous glutamate release. Increased lap expression reversed these phenotypes back to control levels, suggesting that lap may modulate glutamatergic transmission. We also found that lap modulated the localization of amphiphysin (Amph), the homologue of another AD risk factor BIN1, and that Amph itself modulated postsynaptic glutamate receptor (GluRII) localization. We propose a model where PICALM modulates glutamatergic transmission, together with BIN1, to ameliorate synaptic dysfunction and disease progression.